AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 281: H1667-H1674, 2001;
0363-6135/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A corrigendum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirose, M.
Right arrow Articles by Carlson, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirose, M.
Right arrow Articles by Carlson, M. D.
Vol. 281, Issue 4, H1667-H1674, October 2001

Effects of pituitary adenylate cyclase-activating polypeptide on canine atrial electrophysiology

Masamichi Hirose1, Zeng Leatmanoratn2, Kenneth R. Laurita3, and Mark D. Carlson4

1 Department of Pharmacology, Shinshu University School of Medicine, Matsumoto 390-8621, Japan; 2 Department of Biomedical Engineering; 3 School of Medicine and MetroHealth Medical Center, Cleveland 44109-1998; and 4 Department of Medicine, School of Medicine and University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio 44106

We hypothesized that pituitary adenylate cyclase-activating polypeptide (PACAP) activates intracardiac postganglionic parasympathetic nerves and has a different effect than cervical vagal stimulation. We measured effective refractory period (ERP) and conduction velocity at four atrial sites [high right atrium (HRA), low right atrium (LRA), high left atrium (HLA), and low left atrium (LLA)] and minimum atrial fibrillation (AF) cycle length at 12 atrial sites during cervical vagal stimulation and after PACAP in 26 autonomically decentralized, open-chest, anesthetized dogs. PACAP shortened ERP to a similar extent at all four sites (HRA, 58 ± 2.0 ms; LRA, 60 ± 6.3 ms; HLA, 68 ± 11.5 ms; and LLA, 60 ± 8.3 ms). Low- and high-intensity vagal stimulation shortened ERP at the HRA, but not in the other atrial sites (low-intensity stimulation: HRA, 64 ± 4.0 ms; LRA, 126 ± 5.1 ms; HLA, 110 ± 9.5 ms; and LLA, 102 ± 11.5 ms; high-intensity stimulation: HRA, 58 ± 4.2 ms; and HLA, 101 ± 4.0 ms). Conduction velocity was not altered by any intervention. Minimum AF cycle length after PACAP was similar in both atria but was shorter in the right atrium than in the left atrium during vagal stimulation. After atropine administration, no interventions changed ERP. These results suggest that PACAP shortens atrial refractoriness uniformly in both atria through activation of intrinsic cardiac nerves, not all of which are activated by cervical vagal stimulation.

intrinsic cardiac nervous system; vagal nerve stimulation





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online